Assessment of primary eye and skin irritants by in vitro cytotoxicity and phototoxicity models: an in vitro approach of new arginine-based surfactant-induced irritation.
Extensive efforts have been made, recently, to find surfactants with lower irritation potential than those presently commercially available, for use in pharmaceutical and cosmetic preparations. Cytotoxic and phototoxic effects of a novel family of dicationic arginine-diglyceride surfactant compounds, 1,2-diacyl,3-O-(l-arginyl)-rac-glycerol with alkyl chain lengths in the range from 8 to 14 carbon atoms, were compared to three commercial surfactants. The end-points used to assess toxicity were the red blood cell lysis assay and uptake of the vital dye neutral red 24h after dosing (NRU), respectively. Two immortalized cell lines, murine fibroblast cell line, 3T3, and one human keratinocyte cell line, HaCaT, were used as in vitro models to predict the potential phototoxicity which could result in irritation, determined by resazurin reduction to resorufin and neutral red uptake (NRU). All tested surfactants had cytotoxicity effects as demonstrated by and decrease of NR uptake, which showed a clear concentration-response relationship. Concentrations resulting in 50% inhibition of NR uptake (IC(50)) range from 1 microM(-1) (hexadecyl trimethyl ammonium bromide) to 565 microM(-1) (12,12-l-arginine). Erythrocyte haemolysis also showed a clear concentration-response relationship, the 50% of haemolysis ranged from 37 microM(-1) (10,10-l-arginine) to 151 microM(-1) (sodium lauryl sulphate). Phototoxicity was performed with 12,12-l-acetyl-arginine, the most stable chemical structure. The validated 3T3 NRU photoxicity assay was used and revealed a phototoxic potential.
Benavides
T
T
Department Fisiologia-Divisió IV, Facultat de Farmàcia, Av. Joan XXIII s/N, 08028 Barcelona, Spain.
Mitjans
M
M
Martínez
V
V
Clapés
P
P
Infante
M R
MR
Clothier
R H
RH
Vinardell
M P
MP
D000826:Animal Testing Alternatives; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects; D017484:Dermatitis, Phototoxic; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects; D005123:Eye / Q000187:drug effects*; D006801:Humans; D007509:Irritants / Q000633:toxicity*; D015603:Keratinocytes / Q000187:drug effects; D051379:Mice; D012867:Skin / Q000187:drug effects*; D013501:Surface-Active Agents / Q000633:toxicity*; D041701:Swiss 3T3 Cells; D023382:Toxicity Tests, Acute / Q000379:methods
D007509:Irritants; D013501:Surface-Active Agents; D001120:Arginine